Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 8/20 | 0.48 |
| ▸ | ATM | Q13315 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 4/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KLK7 | P49862 | 2/20 | 0.46 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 3/20 | 0.43 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3754005 | 1.00 | TDP1 (0.48) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL9931542 | 1.00 | TDP1 (0.48) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL12604209 | 0.97 | MEN1 (0.48) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL30895563 | 0.97 | MEN1 (0.48) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL18206801 | 0.94 | CA1 (0.49) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL18206800 | 0.94 | CA1 (0.49) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL15893373 | 0.93 | TDP1 (0.44) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL18978546 | 0.91 | TDP1 (0.42) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL15698479 | 0.91 | KLK7 (0.40) | TDP1ATMPOLBNPSR1MEN1 | |
| SCHEMBL21901505 | 0.91 | MEN1 (0.44) | TDP1ATMPOLBNPSR1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4425181-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | Bertis Inc (KR) | 2024-09-04 | — | — | EP | disclosed |
| EP-4392402-A1 | SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES | Mind Medicine, Inc. (US) | 2024-07-03 | — | — | EP | disclosed |
| US-20240115710-A1 | SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES | Mind Medicine, Inc. (US) | 2024-04-11 | — | — | US | disclosed |
| US-11896670-B2 | Synthesis routes to access MDMA prodrugs by using controlled and non-controlled intermediates | Mind Medicine, Inc. (US) | 2024-02-13 | — | — | US | disclosed |
| US-20240011979-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS INC. (KR) | 2024-01-11 | — | — | US | disclosed |
| WO-2023075435-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | 주식회사 베르티스 | 2023-05-04 | — | — | WO | disclosed |
| US-20230066171-A1 | SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES | Mind Medicine, Inc. (US) | 2023-03-02 | — | — | US | disclosed |
| WO-2023028022-A1 | SYNTHESIS ROUTES TO ACCESS MDMA PRODRUGS BY USING CONTROLLED AND NON-CONTROLLED INTERMEDIATES | Mind Medicine, Inc. (US) | 2023-03-02 | — | — | WO | disclosed |
| US-20220283131-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTES | BERTIS CO., LTD. (KR) | 2022-09-08 | — | — | US | disclosed |
| WO-2022050529-A1 | COMPOSITION FOR DETECTING OR MEASURING ANALYTE | ㈜베르티스 | 2022-03-10 | — | — | WO | disclosed |